Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Pentixapharm Holding AG Stock

Price
Target price
€2.33

€2.33

-20.340%
-0.6
-20.340%
-

-

 
Buy 2 Sell 0
Buy 2
Sell 0
20.02.26 / Tradegate WKN: A40AEG / Name: Pentixapharm Holding / Stock / ? /
Latest predictions
19.02.26
-22.37%
buy
16.09.25
37.41%
buy
Show more
Best running prediction
-
16.09.25
37.41%
buy
Your prediction
Pros and Cons of Pentixapharm Holding AG in the next few years
Wizard

Pentixapharm Holding AG Stock

Heavy losses for Pentixapharm Holding AG today as the stock fell by -€0.600 (-20.340%).
What does Pentixapharm Holding do?

Pros and Cons of Pentixapharm Holding AG in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice
Register To Post

News

EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
EQS-News: Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
eqs_en 
0 07.01.26
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
EQS-News: Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
eqs_en 
0 03.12.25
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025
EQS-News: Pentixapharm Publishes 9-Month Figures for 2025
eqs_en 
0 12.11.25